U-BIOPRED clinical
- First Name
- Neil
- Last Name
- Fitch
- Affiliation
- BioSci Consulting
- neilfitch@biosciconsulting.com
- Business Phone Number
- +3289254009
- Business Fax Number
- -
- Business Address
- -
- Project Website
- www.ubiopred.eu
- Version
- 1
- Date of creation of the dataset
- 2017-09-25
- Date of the last update of the dataset
- 2017-09-25
- Funding
- -
- Reference Publications
- https://www.ncbi.nlm.nih.gov/pubmed/26357963 https://www.ncbi.nlm.nih.gov/pubmed/26405287 https://www.ncbi.nlm.nih.gov/pubmed/28842514 https://www.ncbi.nlm.nih.gov/pubmed/28528200 https://www.ncbi.nlm.nih.gov/pubmed/28259448
- Data Standards Implemented
- -
- Therapeutic Area Standards (Disease Area)
- -
- Study Protocal Description
- A observational study of people with mild, moderate and severe asthma including both smokers and non-smokers and a control group of healthy volunteers. An extensive range of clinical parameters and omics from blood, urine, sputum and bronchial brushings and biopsy and nasal brushings.
- Multi-center Study
- True
- Description of Cohorts
- Cohort A adult: Severe asthma non-smoking (under 5 pack years) Cohort B Adult: Severe asthma smoking (5+ pack years) Cohort C Adult: Mild-moderate asthma Cohort D adult: Healthy volunteers Cohort A Paediatric: Severe school aged asthma Cohort B Paediatric: Mild-moderate school aged asthma Cohort C Paediatric: Severe pre-school aged asthma/wheeze Cohort D Paediatric: Mild-moderate pre-school aged asthma/wheeze
- Study Type
- -
- Study Type Comment
- -
- Primary Purpose
- Phenotype severe asthma
- Study Phase
- Yes
- Intervention Model
- -
- Study Classification
- -
- Indication
- -
- Age Range (Low Limit) of Study
- 1
- Age Range (Upper Limit) of Study
- 79
- Age Unit (of the above ranges)
- Year
- BMI Range
- -
- BMI Range (lower limit)
- 17.77
- BMI Range (upper limit)
- 53.63
- Informed Consent
- True
- Planned Arm (Description of Sub-cohorts)
- -
- Name of Treatment
- -
- Standardized Name of Treatment
- -
- Category
- -
- Dose Description
- -
- Organism
- Yes
- Body System or Organ Class
- lung
- Total Number of (Human) Subjects
- -
- Total Number of (Non-Human) Subjects
- -
- Number of Subjects in Each Cohorts (if multi-cohorts)
- Adult: Cohort A: 367 Cohort B: 121 Cohort C: 130 Cohort D: 112 Paediatric Cohort A: 102 Cohort B: 58 Cohort C: 83 Cohort D: 56
- Detail Subject Composition
- -
- Type of Samples Collected
- No
- Number of Samples Collected
- ~20,000
- Samples Details
- Number = total subject numbers (multiple samples per subject) 532 Adult Blood plasma 543 Adult Urine 24 Serum for protemomics 24 Nasal Lavage Supernatant Paediatric A B C D Total Blood 85 43 72 45 245 Sputum 14 6 0 0 20 Urine 92 43 64 45 244 Enose 50 56 106 GWAS 93 43 70 45 251
- Secondary Analysis
- No